Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Aus, NZ propose key features of joint ANZTPA regulations for devices, drugs

This article was originally published in Clinica

Executive Summary

Regulatory agencies in Australia and New Zealand are inviting feedback on "high-level" features of a possible common framework for regulating medical devices, drugs, biologics and other therapeutic products under the ANZTPA – the joint scheme that is being established to regulate therapeutic products in both countries.

Advertisement

Topics

UsernamePublicRestriction

Register